GC
CHNG

Guggenheim Capital’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Guggenheim Capital’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,491
Closed -$206K – 2048
2022
Q3 		$206K Sell
7,491
-35,860
-83% -$889K ﹤0.01% 1788
2022
Q2 		$1M Sell
43,351
-6,676
-13% -$156K 0.01% 1219
2022
Q1 		$1.09M Sell
50,027
-59,344
-54% -$1.23M 0.01% 1322
2021
Q4 		$2.34M Sell
109,371
-1,271
-1% -$26.7K 0.01% 979
2021
Q3 		$2.32M Sell
110,642
-289
-0.3% -$6.3K 0.01% 982
2021
Q2 		$2.56M Buy
110,931
+12,638
+13% +$291K 0.02% 957
2021
Q1 		$2.17M Buy
98,293
+46,476
+90% +$1.08M 0.01% 989
2020
Q4 		$966K Buy
51,817
+18,697
+56% +$307K 0.01% 1360
2020
Q3 		$481K Buy
+33,120
New +$421K ﹤0.01% 1461
2020
Q2 		– Sell
-45,096
Closed -$451K – 1957
2020
Q1 		$451K Buy
+45,096
New +$631K ﹤0.01% 1398

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Guggenheim Capital's CHNG Position: Q4 2022 in Review

Guggenheim Capital sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 7,491 shares — an estimated $206K sold.

Guggenheim Capital first reported a position in CHNG in Q1 2020 and held it in 10 quarters. The position peaked at $2.56M in Q2 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Guggenheim Capital reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Guggenheim Capital sold 7,491 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $206K.
  • Guggenheim Capital first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Guggenheim Capital's Change Healthcare Inc. Common Stock position peaked at $2.56M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.